Yoakim M, Hou W, Liu Y, Carpenter C L, Kapeller R, Schaffhausen B S
Department of Biochemistry, Tufts University School of Medicine, Boston, Massachusetts 02111.
J Virol. 1992 Sep;66(9):5485-91. doi: 10.1128/JVI.66.9.5485-5491.1992.
The binding of phosphatidylinositol-3-kinase to the polyomavirus middle T antigen is facilitated by tyrosine phosphorylation of middle T on residue 315. The pp85 subunit of phosphatidylinositol-3-kinase contains two SH2 domains, one in the middle of the molecule and one at the C terminus. When assayed by blotting with phosphorylated middle T, the more N-terminal SH2 domain is responsible for binding to middle T. When assayed in solution with glutathione S transferase fusions, both SH2s are capable of binding phosphorylated middle T. While both SH2 fusions can compete with intact pp85 for binding to middle T, the C-terminal SH2 is the more efficient of the two. Interaction between pp85 or its SH2 domains and middle T can be blocked by a synthetic peptide comprising the tyrosine phosphorylation sequence around middle T residue 315. Despite the fact that middle T can interact with both SH2s, these domains are not equivalent. Only the C-terminal SH2-middle T interaction was blocked by anti-SH2 antibody; the two SH2 fusions also interact with different cellular proteins.
315位酪氨酸磷酸化促进了磷脂酰肌醇-3激酶与多瘤病毒中T抗原的结合。磷脂酰肌醇-3激酶的pp85亚基包含两个SH2结构域,一个位于分子中部,另一个位于C末端。当用磷酸化的中T进行印迹分析时,更靠近N末端的SH2结构域负责与中T结合。当用谷胱甘肽S转移酶融合蛋白在溶液中进行分析时,两个SH2结构域都能够结合磷酸化的中T。虽然两个SH2融合蛋白都可以与完整的pp85竞争结合中T,但C末端的SH2在两者中效率更高。pp85或其SH2结构域与中T之间的相互作用可被包含中T 315位残基周围酪氨酸磷酸化序列的合成肽阻断。尽管中T可以与两个SH2结构域相互作用,但这些结构域并不等同。只有C末端的SH2-中T相互作用被抗SH2抗体阻断;两个SH2融合蛋白也与不同的细胞蛋白相互作用。